is glp 1 insulin Science Behind GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements GLP-1 & GIP Agonists |
Description
Chan DC, Watts GF, Ng TWK, Yamashita S, Barrett PHR
D., Schneider, M
The United States, in particular, represents a large market for GLP-1 receptor agonists, driven by the presence of key pharmaceutical players and high levels of healthcare investment
The company's website clarifies that Patchie does not include any pharmaceutical actives, but clearer marketing language could prevent confusion
3094, bringing the total number to 1,221
